This Vial Could Hold the Key to a $172 Billion Secret

When most people look at this vial, all they see is an ordinary bottle of liquid.

But when Silicon Valley’s most legendary tech investors look at it, they see one of the biggest new technologies of the 21st century.

When officials at the Food and Drug Administration look at it, they see a new technology that “holds out the potential to transform medicine.”

When 12-year-old Alicia Thompson looks at it, she sees the groundbreaking creation that gave her back her life.

And when acclaimed biotech investment expert Paul Mampilly looks at it, he sees an incredible innovation that is all of the above – and an opportunity for investors like you to help save lives and make millions while doing it.

Paul recently went on stage to reveal the shocking details on why this new “living technology” could hold the key to a technology revolution poised to reach $172 billion.

According to Paul, scientists at both Harvard and Berkeley have declared this will be “THE technology of the 21st century.”

Pharmaceutical giants – including Merck, Novartis and Roche – are already spending billions of dollars in a race to ink deals that would allow them to get their hands on it.

Some of the biggest names in Silicon Valley are investing millions of their own money in it.

And Paul has identified the company at the forefront of it all.

If history is any indication, early investors could stand to make up to 23 TIMES their money, as he shows in this special video presentation.

To be clear: This stock, trading for about $16 at the moment, is poised to soar as high as 2,300% in the years ahead.

Click here to see why.

 

 

 


Legal Notice: This work is based on what we’ve learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It’s your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Don’t trade in these markets with money you can’t afford to lose. Investing in stock markets involves the risk of loss. Before investing you should consider carefully the risks involved, if you have any doubt as to suitability or the taxation implications, seek independent financial advice. Banyan Hill Publishing expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Banyan Hill Publishing, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail.

(c) 2018 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096)